secwatch.observer — SEC 8-K summary
======================================

Issuer:     PTC THERAPEUTICS, INC. (PTCT)
CIK:        0001070081
Form:       8-K
Filed at:   2022-12-06T23:59:59+00:00
Accession:  0001104659-22-124889
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PTC Therapeutics board member Dawn Svoronos resigns, enters consulting agreement; bylaws updated
--------------------------------------------------------------------------------

- Dawn Svoronos resigned from the board effective Dec 6, 2022; no disagreement with the company.
- Enters consulting agreement at $300/hour, term through March 31, 2023.
- Bylaws amended to permit virtual-only shareholder meetings and adjust proxy procedures.
- New exclusive forum provisions: Delaware Chancery for derivative claims, federal courts for Securities Act claims.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070081/000110465922124889/0001104659-22-124889-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070081/000110465922124889/tm2232094d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-124889

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer